Sgrùdaidhean clionaigeach Lupus ann an California
Tha 27 sgrùdaidhean airson Lupus a’ lorg phàirtichean aig làraichean ann an California.
Bailtean ann an California
- Santa Monica8 sgrùdaidhean
- Los Angeles8 sgrùdaidhean
- San Diego7 sgrùdaidhean
- Buena Park7 sgrùdaidhean
- Fullerton5 sgrùdaidhean
- San Francisco4 sgrùdaidhean
- San Leandro3 sgrùdaidhean
- Upland3 sgrùdaidhean
- Sacramento3 sgrùdaidhean
Teacsa sgrùdaidh oifigeil (Beurla)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50737, Beverly Hills
- Sl0044 50775, Beverly Hills
- Sl0044 50257, La Jolla
- agus 6 a bharrachd
A’ fastadhÌre 3
Aoisean 16 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06617325Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Ronald Reagan UCLA Medical Center, Los Angeles
A’ fastadhÌre 2
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT05268289A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Wallace & Lee Center, Beverly Hills
- Arthritis & Osteoporosis Medical Center, Inc - La Palma, La Palma
- University of California San Diego, San Diego
- agus 3 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07409181Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Providence Medical Center, Burbank
- Advanced Medical Research, La Palma
A’ fastadhÌre 3
Aoisean 12 gu 100 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06133972An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, Los Angeles
A’ fastadhÌre 3
Aoisean 5 gu 17 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT05835310A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Fontana
- Research Site, La Jolla
- Research Site, La Palma
- agus 3 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07430306A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- David S Hallegua MD A Professional Corporation, Beverly Hills
- Providence Medical Foundation, Fullerton
- Southland Arthritis and Osteoporosis Medical Center Inc dba Southland Arthritis, Hemet
- agus 5 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07438496A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- Solace Research /ID# 279155, Tustin
A’ fastadhÌre 1
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07607964Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT03816345Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
- Research Site, Fullerton
A’ fastadhÌre 1
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT07201558A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, La Jolla
- Research Site, Sacramento
A’ fastadhÌre 1
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06916806Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
- University of California San Francisco - Zuckerberg San Francisco General, San Francisco
A’ fastadhÌre 1
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06975787A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
- Inland Rheumatology Clinical Trials, Inc., Upland
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07355218A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- Wallace Rheumatic Studies Center, Beverly Hills
- Kaiser Permanente Fontana, Fontana
- Providence Medical Foundation, Fullerton
- agus 2 a bharrachd
A’ fastadhÌre 2
Aoisean 12 gu 70 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07570862A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
- Dermatology Research Associates - 300204025, Los Angeles
- Cohen Medical Centers, Thousand Oaks
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT07332481A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, San Francisco
- Research Site, Stanford
A’ fastadhÌre 1/2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Loma Linda University Medical Center, Loma Linda
A’ fastadhÌre 1
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT07085104A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Local Institution - 0054, La Jolla
- Local Institution - 0001, La Palma
- Local Institution - 0071, Los Angeles
- agus 1 a bharrachd
A’ fastadhSgrùdadh amharc
Aoisean 16 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07175285FT839 in Autoimmune Diseases
- Providence Medical Foundation, Fullerton
A’ fastadhÌre 1/2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07800871A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- UC San Diego Health, La Jolla
- Stanford University Medical Center, Redwood City
A’ fastadhÌre 1
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT06925542RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of California Irvine, Orange
- UC Davis Health, Sacramento
A’ fastadhÌre 1/2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT06121297Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- University of California, Los Angeles, Los Angeles
- University of California: San Diego, San Diego
A’ fastadhÌre 3
Aoisean 55 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT05799378A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Beverly Hills
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07260877Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
- Carewell Arthritis Center, Apple Valley
- Attune Health Research Inc, Beverly Hills
- Covina Arthritis Clinic, Covina
- agus 4 a bharrachd
A’ fastadhÌre 1
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 20 Iuch 2026 · NCT07237659A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
- US06-0, La Palma
A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 2 Ògmh 2026 · NCT06625671A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Wallace Rheumatic Center, Beverly Hills
- Providence Medical Foundation, Fullerton
- University of California Irvine, Irvine
- agus 2 a bharrachd
A’ fastadhÌre 1
Aoisean 12 gu 70 · Gach gnè · Air ùrachadh 22 Cèit 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- Wallace Rheumatic Studies Center, Beverly Hills
- UCLA, Los Angeles
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 110 · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT05934149Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.